In this video, the physician-scientist shares his story and announces the creation of a new nonprofit, Every Cure, to better identify generic drugs that could help people with rare diseases.
David Fajgenbaum ’03 is one of the youngest individuals ever appointed to the faculty at Penn Medicine. He is also the national best-selling author of “Chasing My Cure: A Doctor’s Race to Turn Hope Into Action,” in which he tells the story of how he found the cure for his own rare and deadly disease during medical school. He has identified and advanced 11 other treatments for autoimmunity and cancer and was a driving force behind the CORONA project, a database to discover possible treatments for COVID-19 among existing drug therapies.
Here, during the opening session of the Clinton Global Initiative in September 2022, he shares his own inspirational story and announces the launch of Every Cure, a nonprofit with the mission to unlock the full potential of FDA-approved medicines to treat every disease possible. His speech is followed by brief remarks about the initiative from former President Bill Clinton.
Launch of Every Cure at the 2022 Clinton Global Initiative
About David Fajgenbaum ’03
Fajgenbaum earned a Bachelor of Science from Georgetown University, a Master of Science from the University of Oxford, a Doctor of Medicine from the University of Pennsylvania and a Master in Business Administration from The Wharton School. He has been profiled by The New York Times, “The Today Show,” “Good Morning America” and others and has received numerous awards and recognitions, including the 2016 Atlas Award and Forbes Magazine’s 30 Under 30. He is currently an assistant professor at the Perelman School of Medicine of the University of Pennsylvania.
David Fajgenbaum ’03